Health

After $7.1 Billion Sale Of Frutarom, Ori Yehudai To Join The Sade Group As Active Chairman and Investor

NESS ZIONA, Israel, May 27, 2019 /PRNewswire/ -- Ori Yehudai: "I took a company worth$3 million and sold it to IFF at $7.1 billion in 2018. In my opinion, the success of our cannabis company will be to build an industrial pharmaceutical company with the strictest standards, we had two such plants...

2019-05-27 20:05 2555

imSure Conducted Voluntary Health Insurance Scheme (VHIS) and Insurance Purchase Behavioral Research

HONG KONG, May 27, 2019 /PRNewswire/ -- The Voluntary Health Insurance Scheme (VHIS) was launched in early April this year. imSure, an online insurance comparison platform, has recently commissioned the Consumer Search Group to engage approximately 1,000Hong Kong residents aged between 18 and 64 ...

2019-05-27 17:59 4240

Sihuan Pharm Becomes the First Chinese Company that was Granted Approval for "Non-PVC Solid-Liquid Double Chamber Bag for Ceftazidime/Sodium Chloride Injection"

HONG KONG, May 27, 2019 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Group"), the largest cardio-cerebral vascular ("CCV") drug manufacturer in China's prescription drug market, announced the "non-PVC solid-liquid double chamber bag for ...

2019-05-27 17:08 5062

CALECIM(R) forms a major partnership with Menarini Asia-Pacific to expand the presence of its stem cell skin care products in the region

SINGAPORE, May 27, 2019 /PRNewswire/ -- CALECIM® Cosmeceuticals (CALECIM®), a wholly owned subsidiary of biotechnology company CellResearch Corporation (CRC), has formed a major partnership with A. Menarini Asia-Pacific Holdings Pte. Ltd. (Menarini Asia-Pacific). The multi-year partnership covers...

2019-05-27 15:00 3516

CALECIM(R) partners Menarini Asia-Pacific to expand reach of its stem cell skin care products in the region

SINGAPORE, May 27, 2019 /PRNewswire/ -- CALECIM® Cosmeceuticals (CALECIM®), a wholly owned subsidiary of biotechnology company CellResearch Corporation (CRC), has formed a major partnership with A. Menarini Asia-Pacific Holdings Pte. Ltd. (Menarini Asia-Pacific). The multi-year partnership covers...

2019-05-27 09:00 4200

111 to Collaborate with MSH to Build Internet Pharmaceutical and Healthcare Service Closed-loop System

SHANGHAI, May 24, 2019 /PRNewswire/ -- Following 111, Inc.'s (NASDAQ: YI) ("111" or the "Company") strategic partnership with Manulife-Sinochem last year, the Company has reached another milestone. OnMay 24, 111 and MSH, a world leader in the design and management of international healthcare solu...

2019-05-24 22:45 8415

Five Directors of Golden Meditech Voluntarily Resigned Due to Personal Reasons

New Members on Board, the Company's Major Shareholder Maintains Full Confidence in Future Business Development HONG KONG, May 24, 2019 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) ("Golden Meditech" or the "Company", together with its subsidiaries, the "Group"), a l...

2019-05-24 21:50 14047

CTONG-OrigiMed New Clinical Trial Sharing Platform Launched during the 3rd OrigiMed Summit for Cancer Discovery

SHANGHAI, May 24, 2019 /PRNewswire/ -- With fast advances in the medical industry, onMay 11, 2019, the third OrigiMed Summit for Cancer Discovery: Immunotherapy and Targeted Therapy was successfully held inGuangzhou. The summit was sponsored by the Chinese Thoracic Oncology Group (CTONG) and the ...

2019-05-24 19:00 4470

B dot Medical Developing Ultra-compact Proton Cancer Therapy System That Can Replace X-ray Cancer Therapy System

TOKYO, May 24, 2019 /PRNewswire/ -- B dot Medical Inc. announced on May 24 that the company has initiated the development of an ultra-compact proton cancer therapy system that can replace the commonly used x-ray cancer therapy system (LINAC). More than 180,000 patients have been treated in proto...

2019-05-24 14:00 2525

Menicon Announces Launch of Menicon Bloom Myopia Control Management System

- Launch Features Initial Introduction of Menicon Bloom Night, First and Only CE-approved Orthokeratology Contact Lens inEurope for Myopia Control - NAGOYA, Japan, May 24, 2019 /PRNewswire/ -- Menicon Co., Ltd. announced on May 24 the launch of the Menicon Bloom Myopia Control Management System, ...

2019-05-24 13:00 3806

Elekta Unity MR-linac Receives Regulatory Approval From Japanese Ministry of Health, Labour and Welfare

With the potential to transform how clinicians treat cancer, Japan enters a new era of precision radiation medicine with magnetic resonance radiation therapy TOKYO, May 24, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that its Elekta Unity magnetic resonance radiation therapy system ha...

2019-05-24 07:05 7424

Ovid Therapeutics to Present at the 12th International Epilepsy Colloquium

First scientific presentation of OV-935 (TAK-935) safety and tolerability data in developmental and epileptic encephalopathies from the Phase1b/2a clinical trial Study met primary safety and tolerability endpoints and showed initial evidence of potential efficacy in seizure reduction Data encou...

2019-05-24 05:04 7436

/C O R R E C T I O N -- World Federation of Hemophilia/

In the news release, The World Federation of Hemophilia (WFH) welcomes Bayer AG to the WFH Humanitarian Aid Program, issued23-May-2019 by World Federation of Hemophilia over PRNewswire, we are advised by the company that the name 'Bayer AG' should have been 'Bayer'. The complete, corrected rel...

2019-05-24 04:02 2533

APRINOIA Therapeutics Awarded Grant from The Michael J. Fox Foundation for Parkinson's Research

TAIPEI, , May 23, 2019 /PRNewswire/ -- APRINOIA Therapeutics, a clinical-stage biotechnology company with a pipeline of therapeutics and imaging diagnostics for neurodegenerative diseases, announces today that it has been awarded a research grant from The Michael J. Fox Foundation for Parkinson'...

2019-05-23 20:00 2934

MGI introduces total solution for single cell RNA sequencing using MGISEQ-2000 sequencing platform compatible with 10x Genomics

TOKYO, May 23, 2019 /PRNewswire/ -- MGI , a subsidiary of global genomics leader BGI Group, announced it will begin marketing a total solution for single cell RNA Sequencing as part of the 10x Genomics' Compatible Product Partner Program on MGI's MGISEQ and BGISEQ sequenci...

2019-05-23 19:02 2908

Cstone partner Agios Announces the Phase 3 ClarIDHy Trial of TIBSOVO (ivosidenib) Achieved its Primary Endpoint

SUZHOU, China, May 23, 2019 /PRNewswire/ -- The partner of CStone Pharmaceuticals ("Cstone"; HKEX:2616), Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) ("Agios") announced that the global Phase 3 ClarIDHy trial of TIBSOVO (ivosidenib) in previously treated cholangiocarcinoma patients with an isocitr...

2019-05-23 18:36 3620

Phebra establishes new subsidiary in Canada and announces marketing approval for its IV Arsenic Trioxide Solution

SYDNEY, May 23, 2019 /PRNewswire/ -- Australian pharmaceutical firm Phebra (the 'Company') has continued its international business expansion with the opening of its subsidiary inMontreal, Canada. The new entity, Phebra Canada, will be headed byTony Romagnino, Vice President of Phebra's current N...

2019-05-23 17:00 1781

Bened Biomedical Co., Ltd.: Psychobiotic PS128(TM) found to be a potential solution for Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD)

TAIPEI, , May 23, 2019 /PRNewswire/ -- The possible correlation between autism spectrum disorder (ASD) and gut microbiota has long been explored. A recent study, published in《Nutrients》, shows that a specific probiotic supplementation composed ofLactobacillus plantarum PS128 (Psychobiotic PS128™,...

2019-05-23 11:45 2495

Menarini Ricerche at the ASCO Annual Meeting 2019 With Three Different Projects in Oncology

POMEZIA, Italy, May 23, 2019 /PRNewswire/ -- Menarini Ricerche will present three different projects related to the compounds in clinical development SEL24/MEN1703, MEN1611 and MEN1309/OBT076 at the ASCO Annual Meeting 2019 in Chicago. During the poster session "Breast Cancer – Metastatic" on Jun...

2019-05-23 08:00 2590

2019 Competitive Benchmarking of Leading Oncology Organizations: Commercialization Trends That are Shaping the U.S. Solid and Liquid Tumor Marketplaces

PharmaForce International's 2019 Oncology Studies benchmark key expenditures and organizational approaches of leading Oncology sales and marketing organizations around the globe.The United States is just one of five regions that PFI covers in the Oncology market. READING, Pennsylvania, May 23, 2...

2019-05-23 07:00 1555
1 ... 808809810811812813814 ... 819